Ablation of cyclase-associated protein 2 (CAP2) leads to cardiomyopathy

Peche, Vivek S.; Holak, Tad A.; Burgute, Bhagyashri D.; Kosmas, Kosmas; Kale, Sushant P.; Wunderlich, Frank Thomas; Elhamine, Fatiha; Stehle, Robert; Pfitzer, Gabriele; Nohroudi, Klaus; Addicks, Klaus; Stöckigt, Florian; Schrickel, Jan W.; Gallinger, Julia; Schleicher, Michael; Noegel, Angelika A.

doi:10.1007/s00018-012-1142-y

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Ablation of cyclase-associated protein 2 (CAP2) leads to cardiomyopathy

MPS-Authors

/persons/resource/persons147349

Wunderlich, Frank Thomas
Wunderlich – Obesity and Cancer, Department Brüning, Max Planck Institute for Metabolism Research, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Peche, V. S., Holak, T. A., Burgute, B. D., Kosmas, K., Kale, S. P., Wunderlich, F. T., et al. (2013). Ablation of cyclase-associated protein 2 (CAP2) leads to cardiomyopathy. Cellular and Molecular Liefe Sciences, 70(3), 527-543. doi:10.1007/s00018-012-1142-y.

Cite as: https://hdl.handle.net/11858/00-001M-0000-0026-D1D2-1

Item

Ablation of cyclase-associated protein 2 (CAP2) leads to cardiomyopathy

MPS-Authors

External Resource

Fulltext (restricted access)

Fulltext (public)

Supplementary Material (public)

Citation

Abstract